Pelican Therapeutics, a Subsidiary of Heat Biologics, Receives Second Tranche of its $15.2 Million CPRIT Grant Award Oct 30, 2017
Heat Biologics and its Pelican Therapeutics Subsidiary Appoint Two New Members to their Scientific Advisory Boards Oct 23, 2017
Heat Biologics Announces Pricing for Rights Offering to Stockholders and Participating Warrant Holders Oct 16, 2017
Pelican Therapeutics Announces Manufacturing Agreement with KBI Biopharma to Advance Cancer-targeting Immunotherapies Sep 27, 2017
Heat Biologics Granted Type C Meeting with FDA to Discuss Registrational Pathway for HS-110 in Combination with Opdivo(R) as a Treatment for Non-Small Cell Lung Cancer Sep 12, 2017
Heat Biologics to Present at the 19th Annual Rodman & Renshaw Global Investment Conference in New York Sep 7, 2017
